相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multidisciplinary management of acromegaly: A consensus
Andrea Giustina et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)
Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database
V. Amodru et al.
ENDOCRINE (2020)
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Monica R. Gadelha et al.
ENDOCRINE REVIEWS (2019)
Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly
Federico Gatto et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2019)
Laboratory investigations in the diagnosis and follow-up of GH-related disorders
Katharina Schilbach et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2019)
Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study
Jakob Dal et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Discordance between mass spectrometry and immunometric IGF-1 assay in pituitary disease: a prospective study
Vivien Bonert et al.
PITUITARY (2018)
Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly
Baldomero Gonzalez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
A Consensus Statement on acromegaly therapeutic outcomes
Shlomo Melmed et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database
Federico Gatto et al.
ENDOCRINE (2018)
Quality of Life in Acromegaly
Susan M. Webb et al.
NEUROENDOCRINOLOGY (2016)
The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis
G. A. Kanakis et al.
CLINICAL ENDOCRINOLOGY (2016)
Evolution of Glucose Tolerance After Treatment of Acromegaly: A Study in 57 Patients
C. Jonas et al.
HORMONE AND METABOLIC RESEARCH (2016)
The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study
Lakshminarayanan Varadhan et al.
PITUITARY (2016)
Clinical importance of achieving biochemical control with medical therapy in adult patients with acromegaly
Elena A. Christofides
PATIENT PREFERENCE AND ADHERENCE (2016)
The Introduction of the IDS-iSYS Total IGF-1 Assay May Have Far-Reaching Consequences for Diagnosis and Treatment of GH Deficiency
A. J. Varewijck et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies
Cornelie D. Andela et al.
PITUITARY (2015)
Acromegaly: An Endocrine Society Clinical Practice Guideline
Laurence Katznelson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
EXPERT CONSENSUS DOCUMENT A consensus on the medical treatment of acromegaly
Andrea Giustina et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Complex Rhythmicity and Age Dependence of Growth Hormone Secretion Are Preserved in Patients With Acromegaly: Further Evidence for a Present Hypothalamic Control of Pituitary Somatotropinomas
Antonio Ribeiro-Oliveira et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Automated 22-kD Growth Hormone-Specific Assay without Interference from Pegyisomant
Jenny Manolopoulou et al.
CLINICAL CHEMISTRY (2012)
Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays
David R. Clemmons
CLINICAL CHEMISTRY (2011)
The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly
C. N. Jayasena et al.
CLINICAL ENDOCRINOLOGY (2011)
Hypothesis: Extra-hepatic acromegaly: a new paradigm?
Sebastian J. Neggers et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery
Kristine Z. Rubeck et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
A Consensus on Criteria for Cure of Acromegaly
A. Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?
Pamela U. Freda
CLINICAL ENDOCRINOLOGY (2009)
The Utility of Oral Glucose Tolerance Testing for Diagnosis and Assessment of Treatment Outcomes in 166 Patients with Acromegaly
John D. Carmichael et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Acromegaly pathogenesis and treatment
Shlomo Melmed
JOURNAL OF CLINICAL INVESTIGATION (2009)
Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly
Philippe Chanson et al.
CLINICAL ENDOCRINOLOGY (2008)
Divergence between growth hormone and insulin-like growth factor-I concentrations in the follow-up of acromegaly
Orsalia Alexopoulou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Growth hormone response during oral glucose tolerance test:: The impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index
Ayman M. Arafat et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Pegvisomant interference in GH assays results in underestimation of GH levels
A. N. Paisley et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL)
R Trepp et al.
CLINICAL ENDOCRINOLOGY (2005)
Factors influencing mortality in acromegaly
IM Holdaway et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Significance of abnormal nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels
PU Freda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
A Colao et al.
ENDOCRINE REVIEWS (2004)
Treatment of acromegaly with SS analogues: Should GH and IGF-I target levels be lowered to assert a tight control of the disease?
R Cozzi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2004)
分享论文
